Clinical data | |
---|---|
Trade names | Benfuran, Bentos, Betaclar, Glauconex |
AHFS/Drugs.com | International Drug Names |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank |
|
ChemSpider |
|
UNII | |
KEGG |
|
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C16H21NO4 |
Molar mass | 291.347 g·mol−1 |
3D model (JSmol) | |
| |
| |
NY (what is this?) (verify) |
Befunolol (INN) is a beta blocker with intrinsic sympathomimetic activity used in the management of open-angle glaucoma.[1] It also acts as a β adrenoreceptor partial agonist.[2][3] Befunolol was introduced in Japan in 1983 by Kakenyaku Kako Co. under the trade name Bentos.[4]
α1 |
| ||||
---|---|---|---|---|---|
α2 |
| ||||
β |
| ||||